Related Experiment Video
Updated: Jun 5, 2026
12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
[Cognitive intervention in mild cognitive impairment. A review]
Ignacio Demey1, Ricardo F Allegri
1Facultad de Psicología y Educación, Universidad Católica Argentina, Departamento de Neurociencias Cognitivas, Instituto de Neurociencias Buenos Aires (INEBA). idemey@fundacionineba.org
Vertex (Buenos Aires, Argentina)
|December 29, 2010
Summary
Cognitive intervention shows promise for individuals with Mild Cognitive Impairment (MCI), a precursor to dementia. Most studies reviewed reported beneficial effects, suggesting its potential to improve cognitive symptoms and slow dementia progression.
Area of Science:
- Neuroscience
- Gerontology
- Cognitive Psychology
Background:
- Mild Cognitive Impairment (MCI) represents a transitional stage between normal aging and dementia.
- Individuals with MCI face an elevated risk of progressing to dementia.
- The amnestic subtype is the most prevalent form of MCI.
Purpose of the Study:
- To review and synthesize existing literature on the efficacy of cognitive intervention for Mild Cognitive Impairment.
- To assess the utility of non-pharmacological approaches in managing cognitive symptoms associated with MCI.
- To identify potential benefits of cognitive interventions in mitigating dementia progression.
Main Methods:
- Systematic review of publications investigating cognitive intervention in patients with Mild Cognitive Impairment.
- Analysis of studies with varied designs, intervention types, treatment durations, and outcome measures.
- Synthesis of reported outcomes regarding the effectiveness of cognitive training, stimulation, and rehabilitation.
Main Results:
- A majority of reviewed studies reported positive outcomes from cognitive interventions.
- No studies indicated unfavorable results from the implemented cognitive interventions.
- Significant variability exists across studies in terms of methodology and outcome assessment.
Conclusions:
- Cognitive interventions appear beneficial for patients with Mild Cognitive Impairment.
- Further well-designed research is needed to confirm efficacy across MCI subtypes.
- Cognitive interventions may help alleviate symptoms and reduce the rate of dementia progression.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:30Cognitive Development During Adulthood
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
01:17Cognitivism
Cognitive psychology emerged as a significant field in the mid-20th century. It focused on understanding humans' internal mental processes. This approach emphasizes how people perceive, remember, think, and solve problems—elements critical to human cognition.
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
Previously dominated by behaviorism, which prioritized observable behaviors and largely ignored mental processes, psychology transformed in the 1950s. Cognitive psychologists argue that understanding how we think and process information is...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...